MedPath

Nanfang Hospital Southern Medical University

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Allo-HSCT With Alternative Donor in Treatment of Hematologic Malignancy

Not Applicable
Completed
Conditions
Chronic Myeloid Leukemia
Acute Leukemia
Myelodysplastic Syndrome
Interventions
Procedure: HSCT from MSD
Procedure: HSCT from MUD
Procedure: HSCT from HRD
Drug: Antithymocyte globulin
First Posted Date
2015-07-01
Last Posted Date
2020-03-05
Lead Sponsor
Nanfang Hospital, Southern Medical University
Target Recruit Count
876
Registration Number
NCT02487069
Locations
🇨🇳

Department of Hematology,Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

Sorafenib for Prophylaxis of Leukemia Relapse in Allo-HSCT Recipients With FLT3-ITD Positive AML

Phase 2
Completed
Conditions
Hematopoietic Stem Cell Transplantation
Acute Myeloid Leukemia
Interventions
First Posted Date
2015-06-17
Last Posted Date
2019-08-26
Lead Sponsor
Nanfang Hospital, Southern Medical University
Target Recruit Count
202
Registration Number
NCT02474290
Locations
🇨🇳

Department of Hematology,Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

Chemotherapy of NSCLC With or Without Icotinib

Phase 2
Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
First Posted Date
2015-04-30
Last Posted Date
2015-04-30
Lead Sponsor
Nanfang Hospital, Southern Medical University
Target Recruit Count
50
Registration Number
NCT02430974

Study of Chemotherapy Plus Icotinib to Treat EGFR Mutation-positive Non-small-cell Lung Cancer

Phase 2
Conditions
NSCLC
Interventions
First Posted Date
2014-10-22
Last Posted Date
2014-10-22
Lead Sponsor
Nanfang Hospital, Southern Medical University
Target Recruit Count
100
Registration Number
NCT02272127
Locations
🇨🇳

Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong, China

Laparoscopy-assisted and Open Distal Gastrectomy for Gastric Cancer in the Elderly Patients

Phase 3
Conditions
Complications
Interventions
Procedure: Laparoscopic gastrectomy
Procedure: Open gastrectomy
First Posted Date
2014-09-22
Last Posted Date
2017-01-10
Lead Sponsor
Nanfang Hospital, Southern Medical University
Target Recruit Count
202
Registration Number
NCT02246153
Locations
🇨🇳

Nanfang Hospital, Southern Medical University, Guangzhou, China

Megakaryocytic Progenitor Cells for Prophylaxis and Treatment of Thrombocytopenia

Phase 2
Conditions
Hematological Diseases
Thrombocytopenia
Interventions
First Posted Date
2014-09-16
Last Posted Date
2014-09-16
Lead Sponsor
Nanfang Hospital, Southern Medical University
Target Recruit Count
250
Registration Number
NCT02241031
Locations
🇨🇳

Department of Hematology,Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

MSCs Combined With CD25 Monoclonal Antibody and Calcineurin Inhibitors for Treatment of Steroid-resistant aGVHD

Phase 2
Conditions
Acute Graft-versus-host Disease
Interventions
Drug: CD25 monoclonal antibody
Drug: calcineurin inhibitors
Biological: MSCs
First Posted Date
2014-09-16
Last Posted Date
2014-09-16
Lead Sponsor
Nanfang Hospital, Southern Medical University
Target Recruit Count
200
Registration Number
NCT02241018
Locations
🇨🇳

Department of Hematology,Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

MSCs With or Without Peripheral Blood Stem Cell for Treatment of Poor Graft Function and Delayed Platelet Engraftment

Phase 2
Conditions
Stem Cell Transplantation, Hematopoietic
Hematological Diseases
Poor Graft Function
Delayed Platelet Engraftment
Interventions
Biological: PBSC
Biological: MSCs
First Posted Date
2014-09-16
Last Posted Date
2014-09-16
Lead Sponsor
Nanfang Hospital, Southern Medical University
Target Recruit Count
120
Registration Number
NCT02240992
Locations
🇨🇳

Department of Hematology,Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

Perindopril and Telmisartan for the Treatment of Nonalcoholic Fatty Liver Disease

Phase 4
Conditions
Nonalcoholic Fatty Liver Disease (NAFLD)
Interventions
First Posted Date
2014-08-11
Last Posted Date
2014-08-11
Lead Sponsor
Nanfang Hospital, Southern Medical University
Target Recruit Count
180
Registration Number
NCT02213224
Locations
🇨🇳

Nanfang Hospital, Southern Medical University, GuangZhou, Guangdong, China

Observational Study on Patients With Chronic Hepatitis B

Conditions
Chronic Hepatitis B
First Posted Date
2014-06-19
Last Posted Date
2014-06-19
Lead Sponsor
Nanfang Hospital, Southern Medical University
Target Recruit Count
10000
Registration Number
NCT02167503
Locations
🇨🇳

Beijing Ditan Hospital, Beijing, Beijing, China

🇨🇳

Beijing Friendship Hospital Attached to the Capital Medical University, Beijing, Beijing, China

🇨🇳

Department of infectious disease, First Hospital of Peking University, Beijing, Beijing, China

and more 11 locations
© Copyright 2025. All Rights Reserved by MedPath